FDA to increase drug competition and speed up ANDA reviews
28-06-2017
carmendorin / iStockphoto.com
The US Food and Drug Administration (FDA) finalised 46 product-specific bioequivalence guidances in August.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
FDA, Food and Drug Administration, bioequivalence, drugs, generics, reference products
